Technical Analysis for GLMD - Galmed Pharmaceuticals Ltd.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
50 DMA Support | Bullish | 0.00% | |
Crossed Above 20 DMA | Bullish | 0.00% | |
MACD Bullish Signal Line Cross | Bullish | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Fell Below 20 DMA | Bearish | 10.68% | |
MACD Bearish Signal Line Cross | Bearish | 10.68% | |
50 DMA Support | Bullish | 10.68% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 10.68% | |
Narrow Range Bar | Range Contraction | 10.68% |
Alert | Time |
---|---|
Up 5% | about 4 hours ago |
Reversed from Up | about 7 hours ago |
Gap Up Closed | about 7 hours ago |
Rose Above 20 DMA | about 7 hours ago |
20 DMA Support | about 7 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/30/2024
GalMed Medical Research Ltd. researches and develops proprietary drugs for the treatment of lipid metabolism related diseases. The company has developed a series of proprietary fatty acid bile-acid conjugates (FABACs) which selectively inhibit the enzyme Stearoyl-CoA Desaturase (SCD1), a key regulator in lipid metabolism. It's flagship clinical compound Aramchol (arachidyl amido cholanoic acid), has the potential to modify several of the key disorders related to lipid metabolism, including fatty liver, gallstones, diabetes, hyperlipidemia, cancer, and alzheimer's disease. The company is based in Tel Aviv, Israel. GalMed Medical Research Ltd. operates as a subsidiary of Galmed International Ltd.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Acid Diabetes Alzheimer's Disease Lipid Medical Research Metabolism Hepatology Fatty Acids Fatty Liver Hyperlipidemia
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Acid Diabetes Alzheimer's Disease Lipid Medical Research Metabolism Hepatology Fatty Acids Fatty Liver Hyperlipidemia
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 7.764 |
52 Week Low | 0.2601 |
Average Volume | 247,181 |
200-Day Moving Average | 0.55 |
50-Day Moving Average | 0.36 |
20-Day Moving Average | 0.37 |
10-Day Moving Average | 0.38 |
Average True Range | 0.03 |
RSI (14) | 59.02 |
ADX | 24.72 |
+DI | 25.59 |
-DI | 16.68 |
Chandelier Exit (Long, 3 ATRs) | 0.34 |
Chandelier Exit (Short, 3 ATRs) | 0.41 |
Upper Bollinger Bands | 0.43 |
Lower Bollinger Band | 0.30 |
Percent B (%b) | 0.78 |
BandWidth | 34.03 |
MACD Line | 0.01 |
MACD Signal Line | 0.01 |
MACD Histogram | 0.0012 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.47 | ||||
Resistance 3 (R3) | 0.46 | 0.43 | 0.46 | ||
Resistance 2 (R2) | 0.43 | 0.41 | 0.43 | 0.45 | |
Resistance 1 (R1) | 0.41 | 0.40 | 0.42 | 0.42 | 0.45 |
Pivot Point | 0.39 | 0.39 | 0.39 | 0.39 | 0.39 |
Support 1 (S1) | 0.37 | 0.37 | 0.38 | 0.38 | 0.35 |
Support 2 (S2) | 0.34 | 0.36 | 0.34 | 0.35 | |
Support 3 (S3) | 0.33 | 0.34 | 0.34 | ||
Support 4 (S4) | 0.33 |